HeartBeam is a health information services business based in the US. HeartBeam shares (BEAT) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.88 – an increase of 7.35% over the previous week. HeartBeam employs 21 staff and has a market cap (total outstanding shares value) of 0.00.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.88 |
|---|---|
| 52-week range | $1.45 - $3.48 |
| 50-day moving average | $1.90 |
| 200-day moving average | $2.27 |
| Wall St. target price | $5.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.73 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.84 from 2025-05-06
| 1 week (2025-04-30) | 5.14% |
|---|---|
| 1 month (2025-04-08) | 12.20% |
| 3 months (2025-02-07) | -22.69% |
| 6 months (2024-11-08) | -28.40% |
| 1 year (2024-05-08) | -11.96% |
|---|---|
| 2 years (2023-05-05) | -14.39% |
| 3 years (2022-05-06) | 10.18% |
| 5 years (2020-05-04) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -121.82% |
| Return on equity TTM | -221.11% |
| Profit margin | 0% |
| Book value | $0.06 |
| Market Capitalization | $59 million |
TTM: trailing 12 months
We're not expecting HeartBeam to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, HeartBeam's shares have ranged in value from as little as $1.45 up to $3.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HeartBeam's is -0.605. This would suggest that HeartBeam's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, HeartBeam has bucked the trend.
To put HeartBeam's beta into context you can compare it against those of similar companies.
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California. .